Ion channels are major drug targets and the industry has invested heavily in studying them. This year’s Ion Channels in Drug Discovery & Development Conference brings research leaders together to examine the progress in ion channel targeted drug development, the potential of novel targets, the breakthroughs in technologies and the challenges in successful development of ion channel targeting therapies.

Join leaders in the industry for some lively discussion in a setting aimed at facilitating the networking of both industry and academia to move the field forward.

Keynote Presentation:

“A Regulatory Protein Complex Associated with Membrane Ion Channels”
Irwin B. Levitan, Ph.D.
David J. Mahoney, Professor and Chair, Department of Neuroscience
Director, Mahoney Institute of Neurological Sciences
University of Pennsylvania School of Medicine



“Database Tools Remove Analysis Bottleneck and Support Advanced Compound Evaluation”
Alan Finkel, Ph.D.
CTO and Senior VP
Molecular Devices


Conference Chairs:

Jesus "Tito" Gonzalez, Ph.D.
Sr. Director, Ion Transport
Vertex Pharmaceuticals

Valentin Gribkoff, Ph.D.
Vice President, Biology, Scion Pharmaceuticals
Adjunct Associate Professor of Pharmacology, Yale Medical School

Kenneth J. Rhodes, Ph.D.
Research Fellow and Co-Team Leader, Neurological Disorders
Johnson & Johnson Pharmaceutical Research and Development

*Accepting poster abstracts till Sept 4, 2004.